Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-1-21
pubmed:abstractText
The ability of acute myeloid leukaemia (AML) cells to acquire dendritic cell (DC)-like characteristics in vitro with a rapid culture method based either on the phorbol ester PMA or calcium ionophores has been studied in comparison to conventional AML-DC cultures with the cytokines granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor-alpha (TNF-alpha), interleukin-3 (IL-3), SCF, FLT3-L and IL-4. In all AML patients, antigen-presenting cells (APC) could be generated from leukaemic cells in 2 days by incubation with PMA or calcium ionophore (A23187 or ionomycin) in the presence as well as in the absence of IL-4. In 30 out of 36 patients APC could be generated after 2 weeks of culture in cytokine-enriched medium. AML-APC cultured with PMA or calcium ionophores immunophenotypically and functionally were at a more mature stage than those cultured in cytokine-enriched medium. The most mature APC were generated by calcium ionophore A23187 plus IL-4, as evidenced by the higher expression of CD40, CD80, CD86 and HLA-DR. Autologous T cell mediated cytotoxicity towards AML blast cells in vitro was observed in 2 cases tested. The persistence of cytogenetic abnormalities confirmed the leukaemic origin of the AML-APC. The generation of AML-APC was possible from freshly isolated as well as cryopreserved material. Our data show that generation of sufficient AML-APC by A23187 plus IL-4 is feasible, for vaccination purposes, in approximately 70% of AML specimens, offering a time-saving and cost-effective approach in preparing anti-leukaemia vaccines.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0340-7004
pubmed:author
pubmed:issnType
Print
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
17-27
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:12536236-Acute Disease, pubmed-meshheading:12536236-Adult, pubmed-meshheading:12536236-Aged, pubmed-meshheading:12536236-Aged, 80 and over, pubmed-meshheading:12536236-Antigen-Presenting Cells, pubmed-meshheading:12536236-Antigens, CD, pubmed-meshheading:12536236-Antigens, Neoplasm, pubmed-meshheading:12536236-Bone Marrow Cells, pubmed-meshheading:12536236-Calcimycin, pubmed-meshheading:12536236-Calcium, pubmed-meshheading:12536236-Cancer Vaccines, pubmed-meshheading:12536236-Cell Culture Techniques, pubmed-meshheading:12536236-Cryopreservation, pubmed-meshheading:12536236-Cytotoxicity, Immunologic, pubmed-meshheading:12536236-Feasibility Studies, pubmed-meshheading:12536236-Female, pubmed-meshheading:12536236-HLA-DR Antigens, pubmed-meshheading:12536236-Humans, pubmed-meshheading:12536236-Interleukin-4, pubmed-meshheading:12536236-Ionophores, pubmed-meshheading:12536236-Leukemia, Myeloid, pubmed-meshheading:12536236-Lymphocyte Culture Test, Mixed, pubmed-meshheading:12536236-Male, pubmed-meshheading:12536236-Middle Aged, pubmed-meshheading:12536236-Neoplastic Cells, Circulating, pubmed-meshheading:12536236-Neoplastic Stem Cells, pubmed-meshheading:12536236-Reproducibility of Results, pubmed-meshheading:12536236-T-Lymphocytes, Cytotoxic, pubmed-meshheading:12536236-Tetradecanoylphorbol Acetate, pubmed-meshheading:12536236-Time Factors, pubmed-meshheading:12536236-Tissue Preservation, pubmed-meshheading:12536236-Tumor Cells, Cultured, pubmed-meshheading:12536236-Vaccination
pubmed:year
2003
pubmed:articleTitle
Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
pubmed:affiliation
Department of Haematology, VU University Medical Centre, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.
pubmed:publicationType
Journal Article